$71.2 Million is the total value of DCVC Bio GP, LLC's 1 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ABCL | AbCellera Biologics, Inc. | $71,231,000 | -31.8% | 7,305,761 | 0.0% | 100.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AbCellera Biologics, Inc. | 4 | Q3 2022 | 100.0% |
View DCVC Bio GP, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-02-14 |
| 4 | 2021-06-22 |
| 3/A | 2020-12-17 |
| 4 | 2020-12-17 |
| 3 | 2020-12-11 |
View DCVC Bio GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.